Transactions
18
Insider / Organon & Co.
Holzbaur Lynette
SVP and Corporate Controller at Organon & Co.
- Company
- Organon & Co.
- Ticker
- OGN
- First filing on record
- November 6, 2025
- Latest trade on record
- May 6, 2026
- SEC filings
- EDGAR ↗
Holzbaur Lynette, SVP and Corporate Controller at Organon & Co., has disclosed 18 transactions in OGN since November 6, 2025: 1 purchase (1 open-market buy) and 5 sales, worth about $390K at the reported prices. The latest was filed May 7, 2026, 1 day after the trade.
Open-market buys
1
Sales
5
Avg. disclosure lag
1.9d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Holzbaur Lynette made 1 purchase worth $353K and 5 sales worth $37K, plus 12 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Holzbaur Lynette has traded 1 stock on record; the largest by dollars is OGN.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
0 of 5 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| M | Option exercise or conversion | 10 | 43,480 | — |
| F | Shares withheld for tax | 5 | 6,197 | $37K |
| A | Grant or award | 2 | 116,861 | — |
| P | Open-market purchase | 1 | 26,448 | $353K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 12 | 1 · $353K | 3 · $27K |
| 2025 | 6 | 0 | 2 · $10K |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| OGN | Buy P | May 6, 2026 | May 7, 2026 | 1d | 26,448 | $13 | $353K | Form 4 ↗ | ||
| OGN | Option / conversion M | March 31, 2026 | April 2, 2026 | 2d | 6,715 | — | — | derivative | Form 4 ↗ | |
| OGN | Option / conversion M | March 31, 2026 | April 2, 2026 | 2d | 4,252 | — | — | derivative | Form 4 ↗ | |
| OGN | Other A | March 31, 2026 | April 2, 2026 | 2d | 41,736 | — | — | derivative | Form 4 ↗ | |
| OGN | Other A | March 31, 2026 | April 2, 2026 | 2d | 75,125 | — | — | derivative | Form 4 ↗ | |
| OGN | Sell F | March 31, 2026 | April 2, 2026 | 2d | 1,914 | $6 | $11K | Form 4 ↗ | ||
| OGN | Option / conversion M | March 31, 2026 | April 2, 2026 | 2d | 6,715 | — | — | Form 4 ↗ | ||
| OGN | Sell F | March 31, 2026 | April 2, 2026 | 2d | 1,212 | $6 | $6,908 | Form 4 ↗ | ||
| OGN | Option / conversion M | March 31, 2026 | April 2, 2026 | 2d | 4,252 | — | — | Form 4 ↗ | ||
| OGN | Option / conversion M | March 29, 2026 | March 31, 2026 | 2d | 5,319 | — | — | derivative | Form 4 ↗ | |
| OGN | Sell F | March 29, 2026 | March 31, 2026 | 2d | 1,516 | $6 | $8,853 | Form 4 ↗ | ||
| OGN | Option / conversion M | March 29, 2026 | March 31, 2026 | 2d | 5,319 | — | — | Form 4 ↗ | ||
| OGN | Option / conversion M | November 7, 2025 | November 10, 2025 | 3d | 2,417 | — | — | derivative | Form 4 ↗ | |
| OGN | Sell F | November 7, 2025 | November 10, 2025 | 3d | 689 | $7 | $4,623 | Form 4 ↗ | ||
| OGN | Option / conversion M | November 7, 2025 | November 10, 2025 | 3d | 2,417 | — | — | Form 4 ↗ | ||
| OGN | Option / conversion M | November 5, 2025 | November 6, 2025 | 1d | 3,037 | — | — | derivative | Form 4 ↗ | |
| OGN | Sell F | November 5, 2025 | November 6, 2025 | 1d | 866 | $7 | $5,646 | Form 4 ↗ | ||
| OGN | Option / conversion M | November 5, 2025 | November 6, 2025 | 1d | 3,037 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| May 7, 2026 | Form 4 | 0001628280-26-031780 | 1 | published | EDGAR ↗ |
| April 2, 2026 | Form 4 | 0001628280-26-023139 | 8 | published | EDGAR ↗ |
| March 31, 2026 | Form 4 | 0001628280-26-022421 | 3 | published | EDGAR ↗ |
| November 10, 2025 | Form 4 | 0001628280-25-051009 | 3 | published | EDGAR ↗ |
| November 6, 2025 | Form 4 | 0001628280-25-050186 | 3 | published | EDGAR ↗ |
Other insiders at Organon & Co.
- Drinane Juliana Papa Interim Head of Mfg & Supply 15 rows
- Morrissey Joseph T. Jr. Interim CEO 15 rows
- WALSH MATTHEW M Chief Financial Officer 15 rows
- COX CARRIE SMITH Director 14 rows
- Falcione Aaron Chief Human Resources Officer 14 rows
- Nisita Vittorio Head of Global Business Svcs 14 rows
- Stahler Rachel A Chief Information Officer 14 rows
- Weaver Kirke Gen. Counsel & Corp. Secy. 14 rows
- Arjona Ferreira Juan Camilo Head of R&D & CMO 13 rows
- Karp Daniel Executive VP, Corp. Dev. 10 rows
Everyone on file, with contracts and lobbying under the company's name: Organon & Co..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 5 | 18 | November 6, 2025 | May 7, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.